Of course! The CA-125 test, often known as “oncogynecology,” is a blood test that gauges the concentration of the tumor marker CA-125 protein, which is specifically linked to ovarian cancer. It is mostly used to track the effectiveness of treatment in female patients with ovarian cancer and to look for signs of the illness returning. Although its specificity and sensitivity vary, it can also help with the initial diagnosis; hence, it is frequently employed in conjunction with other diagnostic methods.
The inclusion of “health heart diagnostics” healthesh in the CA-125 test’s description highlights how crucial it is to take cardiovascular health into account when treating cancer. Chemotherapy and targeted therapies are two examples of ovarian cancer treatments that may cause cardiotoxic side effects. Thus, keeping an eye on CA-125 aids in more than just cancer management.